MedTrace Logo

Implementing a Combination of Clinical Parameters, Biomarkers and SoCs for the Etiology Diagnoses of Pneumonia in Pediatric Patients

NCT03366454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 188

Last updated 2025-06-04

Study results available
· View outcomes & findings →

Summary

Participants who meet the inclusion and exclusion criteria will be enrolled and then having a daily follow up for maximum of 13 days' hospitalization. Next follow up will be taken time at day 14th after hospitalization date, either on ward or policlinic. The participations will be ended by day 30th after hospitalization date when the called follow up is done by investigator.

Conditions

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED

  • Indonesia Research Partnership on Infectious Disease (INA-RESPOND)

    collaborator UNKNOWN

  • INA-RESPOND Secretariat

    lead OTHER

Principal Investigators

  • Dr. Herman Kosasih, PhD · Ina-Respond

Eligibility

Min Age
2 Months
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-04
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • Indonesia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366454 on ClinicalTrials.gov